Supermoon Capital invested in Applied Cognition, a biotechnology company focused on drugs for glymphatic enhancement, as of July 2026.
Clinical-stage platform therapeutics company developing ways to measure and enhance brain glymphatic function in humans, with the aim of preventing progression of neurodegenerative disorders
Clinical-stage platform therapeutics company developing ways to measure and enhance brain glymphatic function in humans, with the aim of preventing progression of neurodegenerative disorders. Its work combines neuroscience, drug development, diagnostics, clinical research, data science, and AI.